Epithelial ovarian cancer: testing the 'androgens hypothesis'
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
In 1998, Risch proposed a hypothesis for the pathogenesis of ovarian cancer relating to the role of androgens in stimulating epithelial cell proliferation. Although this hypothesis has been widely discussed, direct evidence to support it is scant. To address this issue, we have conducted a detailed analysis of factors possibly associated with high circulating levels of androgens, including polycystic ovary syndrome (PCOS), hirsutism and acne (all clinically associated with hyperandrogenism) using the data collected in an Australia-wide, population-based case-control study. Cases aged 18-79 years with a new diagnosis of invasive epithelial ovarian cancer (n=1276) or borderline malignant tumour (n=315) were identified through a network of clinics and cancer registries throughout Australia. Controls (n=1508) were selected from the National Electoral Roll. Women self-reported a history of PCOS, acne, hirsutism and also use of testosterone supplements or the androgenic medication Danazol. We found no evidence that a history of PCOS, acne or hirsutism was associated with ovarian cancer overall, or with specific subtypes, with the exception of serous borderline tumours that were positively associated with a history of PCOS (OR 2.6; 95% CI 1.0-6.1). Women who had ever used testosterone supplements had an increased risk of ovarian cancer (OR 3.7; 95% CI 1.1-12.0); however, use of the androgenic medication Danazol did not increase risk (OR 1.0; 95% CI 0.4-2.9). Overall, our results do not support the hypothesis that androgen-related disorders increase the risk of ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shih, I.-M., & Kurman, R. J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63708-x · Cited by 1,206
Mortality of Women with Polycystic Ovary Syndrome at Long-term Follow-up
Pierpoint, T., McKeigue, P. M., Isaacs, A. J., Wild, S. H., & Jacobs, H. S. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00035-3 · Cited by 504 · cited 1×
“…et al. 1996), although this finding was based on few exposed cases (nZ7), and has not been confirmed in prospective studies (Coulam et al. 1983, Pierpoint et al. 1998); and only one previous study has investigated the association between acne or hirsutism and ovarian cancer, noting a positive…”
ResultTHE EPIDEMIOLOGY OF POLYCYSTIC OVARY SYNDROME
Solomon, C. G. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70069-4 · Cited by 226 · cited 1×
“In addition, PCOS is a complex disorder associated with alterations in endogenous sex hormone levels, suppression of ovulation, infertility and a number of metabolic disorders including insulin resistance (Solomon 1999).”
Background
Cited by
Epidemiology of epithelial ovarian cancer
Webb, P. M., & Jordan, S. J. (2017) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.08.006 · Cited by 995
Self-citationBarry, J. A., Azizia, M. M., & Hardiman, P. J. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu012 · Cited by 597
Ovarian Cancer: Etiology, Risk Factors, and Epidemiology
HUNN, J., & RODRIGUEZ, G. C. (2012) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31824b4611 · Cited by 324
Diagnosis, Treatment, and Follow-Up of Borderline Ovarian Tumors
Fischerova, D., Zikan, M., Dundr, P., & Cibula, D. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0139 · Cited by 279
Evidence of androgen action in endometrial and ovarian cancers
Gibson, D. A., Simitsidellis, I., Collins, F., & Saunders, P. T. K. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0551 · Cited by 73
“…invasive epithelial ovarian cancer or borderline malignant tumour, there was no evidence that excess androgens due to PCOS or treatment with the synthetic androgen Danazol were correlated with overall risk of ovarian cancer but PCOS did increase the risk of borderline tumours (Olsen et al. 2008).”
Background
Metadata
- Authors
- Olsen, C. M., Green, A. C., Nagle, C. M., Jordan, S. J., Whiteman, D. C., Bain, C. J., Webb, P. M., & on behalf of the Australian Cancer Study Group (Ovarian Cancer) and the Australian Ovarian Cancer Study Group
- Venue
- Endocrine Related Cancer
- Publisher
- Bioscientifica
- Published
- 2008-09-10
- Volume
- 15
- Issue
- 4
- Pages
- 1061-1068
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2116544264
- Cited by
- 100
- References
- 3
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epithelial ovarian cancer: testing the 'androgens hypothesis'. https://app.cochat.ai/papers/10.1677/erc-08-0075
- The paper
- Olsen, C. M., Green, A. C., Nagle, C. M., Jordan, S. J., Whiteman, D. C., Bain, C. J., Webb, P. M., & on behalf of the Australian Cancer Study Group (Ovarian Cancer) and the Australian Ovarian Cancer Study Group. (2008). Epithelial ovarian cancer: testing the 'androgens hypothesis'. Endocrine Related Cancer. https://doi.org/10.1677/erc-08-0075
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.